Tiago E F Arantes1, Claudio Silveira2, Gary N Holland3, Cristina Muccioli4, Fei Yu5, Jeffrey L Jones6, Raquel Goldhardt5, Kevan G Lewis5, Rubens Belfort4. 1. Ocular Inflammatory Disease Center, Stein Eye Institute, and the Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California; Department of Ophthalmology, Universidade Federal de São Paulo, São Paulo, Brazil. 2. Clínica Silveira, Erechim, Rio Grande Do Sul, Brazil; Department of Ophthalmology, Universidade Federal de São Paulo, São Paulo, Brazil. 3. Ocular Inflammatory Disease Center, Stein Eye Institute, and the Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California. Electronic address: uveitis@jsei.ucla.edu. 4. Department of Ophthalmology, Universidade Federal de São Paulo, São Paulo, Brazil. 5. Ocular Inflammatory Disease Center, Stein Eye Institute, and the Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California. 6. Division of Parasitic Diseases and Malaria, Center for Global Health, United States Centers for Disease Control and Prevention, Atlanta, Georgia.
Abstract
PURPOSE: To determine the incidence of, and risk factors for, ocular involvement among people known to have postnatally acquired Toxoplasma gondii infection in a region of southern Brazil where there is a high prevalence of endemic disease. DESIGN: Retrospective longitudinal cohort study. METHODS: Records of 302 patients with serologic evidence of recent T gondii infection (a positive anti-T gondii IgM antibody test) from Erechim, Rio Grande do Sul state, Brazil (1974-2002) were analyzed. The incidence of ocular involvement was calculated in terms of person-years (PY) of follow-up. Risk factors for ocular involvement were analyzed using log-rank and Fisher exact tests. RESULTS: At initial ocular examination (baseline), 30 patients (9.9%) had intraocular inflammation only (anterior chamber cells and flare, vitreous inflammatory reactions, retinal whitening), without clinically apparent necrotizing retinochoroiditis. At baseline, men were more likely to have ocular involvement (P = .043) and antiparasitic treatment was associated with less ocular involvement (P = .015). Follow-up examinations were performed on 255 patients (median follow-up, 13.7 months [range 0.4-261.9 months]). Among those without ocular involvement at baseline, the incidence of necrotizing retinochoroiditis was 6.4/100 PY. Patients >40 years of age at first IgM test had a greater risk of incident necrotizing retinochoroiditis (hazard ratio = 4.47, 95% CI = 1.67-11.93, P = .003) than younger patients. The incidence of recurrent necrotizing retinochoroiditis was 10.5/100 PY. CONCLUSION: Isolated intraocular inflammatory reactions can be an initial manifestation of T gondii infection, with necrotizing retinochoroiditis occurring months or years later. Male sex and older age are risk factors for toxoplasmic retinochoroiditis. Antitoxoplasmic treatment may protect against early ocular involvement.
PURPOSE: To determine the incidence of, and risk factors for, ocular involvement among people known to have postnatally acquired Toxoplasma gondii infection in a region of southern Brazil where there is a high prevalence of endemic disease. DESIGN: Retrospective longitudinal cohort study. METHODS: Records of 302 patients with serologic evidence of recent T gondii infection (a positive anti-T gondii IgM antibody test) from Erechim, Rio Grande do Sul state, Brazil (1974-2002) were analyzed. The incidence of ocular involvement was calculated in terms of person-years (PY) of follow-up. Risk factors for ocular involvement were analyzed using log-rank and Fisher exact tests. RESULTS: At initial ocular examination (baseline), 30 patients (9.9%) had intraocular inflammation only (anterior chamber cells and flare, vitreous inflammatory reactions, retinal whitening), without clinically apparent necrotizing retinochoroiditis. At baseline, men were more likely to have ocular involvement (P = .043) and antiparasitic treatment was associated with less ocular involvement (P = .015). Follow-up examinations were performed on 255 patients (median follow-up, 13.7 months [range 0.4-261.9 months]). Among those without ocular involvement at baseline, the incidence of necrotizing retinochoroiditis was 6.4/100 PY. Patients >40 years of age at first IgM test had a greater risk of incident necrotizing retinochoroiditis (hazard ratio = 4.47, 95% CI = 1.67-11.93, P = .003) than younger patients. The incidence of recurrent necrotizing retinochoroiditis was 10.5/100 PY. CONCLUSION: Isolated intraocular inflammatory reactions can be an initial manifestation of T gondii infection, with necrotizing retinochoroiditis occurring months or years later. Male sex and older age are risk factors for toxoplasmic retinochoroiditis. Antitoxoplasmic treatment may protect against early ocular involvement.
Authors: Florentine U Rutaganira; Jennifer Barks; Mary Savari Dhason; Qiuling Wang; Michael S Lopez; Shaojun Long; Joshua B Radke; Nathaniel G Jones; Amarendar R Maddirala; James W Janetka; Majida El Bakkouri; Raymond Hui; Kevan M Shokat; L David Sibley Journal: J Med Chem Date: 2017-10-09 Impact factor: 7.446
Authors: Jeffrey L Jones; Ricardo B Akstein; Michele C Hlavsa; Adriana S Lopez; Mariana Wilson; Gary N Holland Journal: Am J Trop Med Hyg Date: 2016-04-04 Impact factor: 2.345
Authors: Christiane Maria Ayo; Ana Vitória da Silveira Camargo; Fábio Batista Frederico; Rubens Camargo Siqueira; Mariana Previato; Fernando Henrique Antunes Murata; Aparecida Perpétuo Silveira-Carvalho; Amanda Pires Barbosa; Cinara de Cássia Brandão de Mattos; Luiz Carlos de Mattos Journal: PLoS One Date: 2015-12-16 Impact factor: 3.240
Authors: Jitender P Dubey; Leandra R Ferreira; Mohammad Alsaad; Shiv K Verma; Derron A Alves; Gary N Holland; Glenn A McConkey Journal: PLoS One Date: 2016-05-26 Impact factor: 3.240